|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 519/00 | |
| A61P 3/10 | |||
| A61K 31/4184 | |||
| A61K 31/415 | |||
| A61K 31/454 |
| (11) | Number of the document | 2888005 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13830277.3 |
| Date of filing the European patent application | 2013-08-19 | |
| (97) | Date of publication of the European application | 2015-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/055528 |
| Date | 2013-08-19 |
| (87) | Number | WO 2014/031515 |
| Date | 2014-02-27 |
| (30) | Number | Date | Country code |
| 201261692018 P | 2012-08-22 | US |
| (72) |
APGAR, James, M., US
ARASAPPAN, Ashok, US
BIFTU, Tesfaye, US
CHEN, Ping, US
FENG, Danqing, US
GUIDRY, Erin, US
HICKS, Jacqueline, US
KEKEC, Ahmet, US
LEAVITT, Kenneth, US
LI, Bing, US
MCCRACKEN, Troy, US
SEBHAT, Iyassu, US
QIAN, Xiaoxia, US
WEI, Lan, US
WILKENING, Robert, US
WU, Zhicai, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES |
| NOVEL AZABENZIMIDAZOLE HEXAHYDROFURO[3,2-B]FURAN DERIVATIVES |